These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2631 related articles for article (PubMed ID: 26445347)

  • 1. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
    Martinez-Outschoorn U; Sotgia F; Lisanti MP
    Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Even the Warburg effect can be oxidized: metabolic cooperation and tumor development].
    Cordier-Bussat M; Thibert C; Sujobert P; Genestier L; Fontaine É; Billaud M
    Med Sci (Paris); 2018; 34(8-9):701-708. PubMed ID: 30230466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
    El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
    Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking metabolic reprogramming to therapy resistance in cancer.
    Morandi A; Indraccolo S
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):1-6. PubMed ID: 28065746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity in Cancer Metabolism: New Concepts in an Old Field.
    Gentric G; Mieulet V; Mechta-Grigoriou F
    Antioxid Redox Signal; 2017 Mar; 26(9):462-485. PubMed ID: 27228792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4.
    Martinez-Outschoorn UE; Curry JM; Ko YH; Lin Z; Tuluc M; Cognetti D; Birbe RC; Pribitkin E; Bombonati A; Pestell RG; Howell A; Sotgia F; Lisanti MP
    Cell Cycle; 2013 Aug; 12(16):2580-97. PubMed ID: 23860378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities.
    Ganapathy-Kanniappan S
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):212-220. PubMed ID: 28400131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Warburg effect to Reverse Warburg effect; the new horizons of anti-cancer therapy.
    Benny S; Mishra R; Manojkumar MK; Aneesh TP
    Med Hypotheses; 2020 Nov; 144():110216. PubMed ID: 33254523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth.
    Guido C; Whitaker-Menezes D; Lin Z; Pestell RG; Howell A; Zimmers TA; Casimiro MC; Aquila S; Ando' S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Oncotarget; 2012 Aug; 3(8):798-810. PubMed ID: 22878233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
    Vaupel P; Schmidberger H; Mayer A
    Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
    Li C; Zhang G; Zhao L; Ma Z; Chen H
    World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumoral microvesicle-activated glycometabolic reprogramming in fibroblasts promotes the progression of oral squamous cell carcinoma.
    Jiang E; Xu Z; Wang M; Yan T; Huang C; Zhou X; Liu Q; Wang L; Chen Y; Wang H; Liu K; Shao Z; Shang Z
    FASEB J; 2019 Apr; 33(4):5690-5703. PubMed ID: 30698991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment.
    Martinez-Outschoorn UE; Pavlides S; Howell A; Pestell RG; Tanowitz HB; Sotgia F; Lisanti MP
    Int J Biochem Cell Biol; 2011 Jul; 43(7):1045-51. PubMed ID: 21300172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting respiratory complex I to prevent the Warburg effect.
    Vatrinet R; Iommarini L; Kurelac I; De Luise M; Gasparre G; Porcelli AM
    Int J Biochem Cell Biol; 2015 Jun; 63():41-5. PubMed ID: 25668477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic reprogramming of the tumour microenvironment.
    Xing Y; Zhao S; Zhou BP; Mi J
    FEBS J; 2015 Oct; 282(20):3892-8. PubMed ID: 26255648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic orchestration between cancer cells and tumor microenvironment as a co-evolutionary source of chemoresistance in ovarian cancer: a therapeutic implication.
    Suh DH; Kim HS; Kim B; Song YS
    Biochem Pharmacol; 2014 Nov; 92(1):43-54. PubMed ID: 25168677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic reprogramming in cancer: the art of balance].
    Yi M; Xiang B; Li X; Li G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 38(11):1177-87. PubMed ID: 24316928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic reprogramming of the tumor.
    Ferreira LM; Hebrant A; Dumont JE
    Oncogene; 2012 Sep; 31(36):3999-4011. PubMed ID: 22231450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 132.